Pages that link to "Q38351794"

The following pages link to Anti-MUC1 aptamers: radiolabelling with (99m)Tc and biodistribution in MCF-7 tumour-bearing mice (Q38351794):

Displaying 46 items.

• Nucleic acid aptamers: an emerging frontier in cancer therapy (Q26849947) (← links)
• Current progress of aptamer-based molecular imaging (Q27000472) (← links)
• Applications of aptamers in targeted imaging: state of the art (Q27011511) (← links)
• From ugly duckling to swan: unexpected identification from cell-SELEX of an anti-Annexin A2 aptamer targeting tumors (Q27326068) (← links)
• Solution structure of a truncated anti-MUC1 DNA aptamer determined by mesoscale modeling and NMR (Q27675884) (← links)
• Aptamer-Drug Conjugates (Q28468281) (← links)
• Novel Aptamer-Nanoparticle Bioconjugates Enhances Delivery of Anticancer Drug to MUC1-Positive Cancer Cells In Vitro (Q28476756) (← links)
• Direct validation of aptamers as powerful tools to image solid tumor (Q33632641) (← links)
• Nucleic Acid Aptamers: Clinical Applications and Promising New Horizons (Q34028112) (← links)
• Quantitative PCR analysis of DNA aptamer pharmacokinetics in mice. (Q34976853) (← links)
• A primer-free method that selects high-affinity single-stranded DNA aptamers using thermostable RNA ligase (Q35062592) (← links)
• DNA aptamers against exon v10 of CD44 inhibit breast cancer cell migration (Q35106226) (← links)
• Cell-SELEX aptamer for highly specific radionuclide molecular imaging of glioblastoma in vivo. (Q35112737) (← links)
• Aptamer technology for tracking cells' status & function (Q35673895) (← links)
• Aptamers for Targeted Drug Delivery (Q36155891) (← links)
• DNA aptamers to human immunodeficiency virus reverse transcriptase selected by a primer-free SELEX method: characterization and comparison with other aptamers (Q36178229) (← links)
• In vivo Noninvasive Small Animal Molecular Imaging (Q37083100) (← links)
• A review of therapeutic aptamer conjugates with emphasis on new approaches (Q37277378) (← links)
• Anti-MUC1 nano-aptamers for triple-negative breast cancer imaging by single-photon emission computed tomography in inducted animals: initial considerations (Q37538136) (← links)
• The role of carrier size in the pharmacodynamics of antisense and siRNA oligonucleotides (Q37724167) (← links)
• Applications of aptamers in nanodelivery systems in cancer, eye and inflammatory diseases (Q37815481) (← links)
• Nucleic acid aptamers for clinical diagnosis: cell detection and molecular imaging (Q37821356) (← links)
• Nucleic acid aptamers targeting cell-surface proteins. (Q37837155) (← links)
• Aptamers: turning the spotlight on cells (Q37853940) (← links)
• Selecting Potential Targetable Biomarkers for Imaging Purposes in Colorectal Cancer Using TArget Selection Criteria (TASC): A Novel Target Identification Tool (Q37860943) (← links)
• Molecular aptamers for drug delivery (Q37912756) (← links)
• Molecular imaging with nucleic acid aptamers (Q37916658) (← links)
• Fluorescence imaging agents in cancerology (Q38039070) (← links)
• Aptamers as imaging agents (Q38089899) (← links)
• Application of aptamers in diagnostics, drug-delivery and imaging. (Q38291061) (← links)
• Aptamers: versatile molecular recognition probes for cancer detection (Q38652995) (← links)
• Trends in the Design and Development of Specific Aptamers Against Peptides and Proteins. (Q38777639) (← links)
• Aptamers as Therapeutics (Q39070782) (← links)
• Aptamer-based nanoparticles for cancer targeting (Q39204628) (← links)
• Development of nanoaptamers using a mesoporous silica model labeled with (99m)tc for cancer targeting (Q39363843) (← links)
• Aptamer-quantum dots conjugates-based ultrasensitive competitive electrochemical cytosensor for the detection of tumor cell (Q39483510) (← links)
• PEGylated anti-MUC1 aptamer-doxorubicin complex for targeted drug delivery to MCF7 breast cancer cells (Q39494655) (← links)
• Comparison of (99m)Tc-labeled PR81 and its F(ab')₂ fragments as radioimmunoscintigraphy agents for breast cancer imaging (Q39634203) (← links)
• RNA aptamers and their therapeutic and diagnostic applications (Q39862703) (← links)
• Anti-MUC1 aptamer: A potential opportunity for cancer treatment. (Q48009199) (← links)
• 5TR1 aptamer-PEGylated liposomal doxorubicin enhances cellular uptake and suppresses tumour growth by targeting MUC1 on the surface of cancer cells. (Q48581486) (← links)
• Biodistribution of 99mTc-sunitinib as a potential radiotracer for tumor hypoxia imaging. (Q53087435) (← links)
• Engineered Aptamers to Probe Molecular Interactions on the Cell Surface. (Q53092802) (← links)
• Aptamers and Their Significant Role in Cancer Therapy and Diagnosis. (Q54457076) (← links)
• PET imaging of EGFR expression using an F-labeled RNA aptamer (Q57172087) (← links)
• TNBC Challenge: Oligonucleotide Aptamers for New Imaging and Therapy Modalities (Q93075081) (← links)